Podcasts about focus on allergy

Host: Matt Birnholz, MD Guest: Kevin Fussell, MD Up to one in 10 patients with asthma have severe disease, and of those patients, up to 1.3 million have severe uncontrolled asthma.1-3 Since severe asthma has been associated with reduced lung function and poor outcomes.4,5 Dr Kevin Fussell is here to talk about how a treatment option may help patients with severe eosinophilic asthma as well as how we can use telemedicine to help manage and diagnose them. Chung KF, Wenzel SE, Brozek JL, et al. International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma. Eur Respir J. 2014;43(2):343-373. Hankin CS, Bronstone A, Wang Z, Small MB, Buck P. Estimated prevalence and economic burden of severe, uncontrolled asthma in the United States. J Allergy Clin Immunol. 2013;131(2):AB126. Global Initiative for Asthma. Global strategy for asthma management and prevention. Updated 2020. Available from: https://ginasthma.org/wp-content/uploads/2020/06/GINA-2020-report_20_06_04-1-wms.pdf. Accessed August 22, 2020. Newby C, Agbetile J, Hargadon, B, et al. Lung function decline and variable airway inflammatory pattern: longitudinal analysis of severe asthma. J Allergy Clin Immunol. 2014;134(2):287-294. Global Initiative for Asthma. Difficult-to-treat and severe asthma in adolescent and adult patients 2019. Available from:https://ginasthma.org/wp-content/uploads/2019/04/GINA-Severe-asthma-Pocket-Guide-v2.0-wms-1.pdf. Accessed November 1, 2020. ©2020 AstraZeneca. All rights reserved. US-34513 Last Updated 11/20 ...

Host: Matt Birnholz, MD Guest: Kevin Fussell, MD Up to one in 10 patients with asthma have severe disease, and of those patients, up to 1.3 million have severe uncontrolled asthma.1-3 Since severe asthma has been associated with reduced lung function and poor outcomes.4,5 Dr Kevin Fussell is here to talk about how a treatment option may help patients with severe eosinophilic asthma as well as how we can use telemedicine to help manage and diagnose them. Chung KF, Wenzel SE, Brozek JL, et al. International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma. Eur Respir J. 2014;43(2):343-373. Hankin CS, Bronstone A, Wang Z, Small MB, Buck P. Estimated prevalence and economic burden of severe, uncontrolled asthma in the United States. J Allergy Clin Immunol. 2013;131(2):AB126. Global Initiative for Asthma. Global strategy for asthma management and prevention. Updated 2020. Available from: https://ginasthma.org/wp-content/uploads/2020/06/GINA-2020-report_20_06_04-1-wms.pdf. Accessed August 22, 2020. Newby C, Agbetile J, Hargadon, B, et al. Lung function decline and variable airway inflammatory pattern: longitudinal analysis of severe asthma. J Allergy Clin Immunol. 2014;134(2):287-294. Global Initiative for Asthma. Difficult-to-treat and severe asthma in adolescent and adult patients 2019. Available from:https://ginasthma.org/wp-content/uploads/2019/04/GINA-Severe-asthma-Pocket-Guide-v2.0-wms-1.pdf. Accessed November 1, 2020. ©2020 AstraZeneca. All rights reserved. US-34513 Last Updated 11/20 ...

Host: Matt Birnholz, MD Guest: Kevin Fussell, MD Up to one in 10 patients with asthma have severe disease, and of those patients, up to 1.3 million have severe uncontrolled asthma.1-3 Since severe asthma has been associated with reduced lung function and poor outcomes.4,5 Dr Kevin Fussell is here to talk about how a treatment option may help patients with severe eosinophilic asthma as well as how we can use telemedicine to help manage and diagnose them. Chung KF, Wenzel SE, Brozek JL, et al. International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma. Eur Respir J. 2014;43(2):343-373. Hankin CS, Bronstone A, Wang Z, Small MB, Buck P. Estimated prevalence and economic burden of severe, uncontrolled asthma in the United States. J Allergy Clin Immunol. 2013;131(2):AB126. Global Initiative for Asthma. Global strategy for asthma management and prevention. Updated 2020. Available from: https://ginasthma.org/wp-content/uploads/2020/06/GINA-2020-report_20_06_04-1-wms.pdf. Accessed August 22, 2020. Newby C, Agbetile J, Hargadon, B, et al. Lung function decline and variable airway inflammatory pattern: longitudinal analysis of severe asthma. J Allergy Clin Immunol. 2014;134(2):287-294. Global Initiative for Asthma. Difficult-to-treat and severe asthma in adolescent and adult patients 2019. Available from:https://ginasthma.org/wp-content/uploads/2019/04/GINA-Severe-asthma-Pocket-Guide-v2.0-wms-1.pdf. Accessed November 1, 2020. ©2020 AstraZeneca. All rights reserved. US-34513 Last Updated 11/20 ...

Host: Linda Bernstein, Pharm.D. Allergic reactions to peanut are unpredictable in occurrence and in how they present, with some individuals experiencing severe reactions from even trace amounts. Fortunately, there's now an FDA-approved treatment option available that—when used in conjunction with peanut avoidance—can help reduce the risk of these allergic reactions in children with peanut allergy, as pharmacist Dr. Linda Bernstein explains.

Host: Linda Bernstein, Pharm.D. Allergic reactions to peanut are unpredictable in occurrence and in how they present, with some individuals experiencing severe reactions from even trace amounts. Fortunately, there's now an FDA-approved treatment option available that—when used in conjunction with peanut avoidance—can help reduce the risk of these allergic reactions in children with peanut allergy, as pharmacist Dr. Linda Bernstein explains.

Host: Linda Bernstein, Pharm.D. Allergic reactions to peanut are unpredictable in occurrence and in how they present, with some individuals experiencing severe reactions from even trace amounts. Fortunately, there’s now an FDA-approved treatment option available that—when used in conjunction with peanut avoidance—can help reduce the risk of these allergic reactions in children with peanut allergy, as pharmacist Dr. Linda Bernstein explains.

Host: Linda Bernstein, Pharm.D. Allergic reactions to peanut are unpredictable in occurrence and in how they present, with some individuals experiencing severe reactions from even trace amounts. Fortunately, there’s now an FDA-approved treatment option available that—when used in conjunction with peanut avoidance—can help reduce the risk of these allergic reactions in children with peanut allergy, as pharmacist Dr. Linda Bernstein explains.

Host: Jennifer Caudle, DO Guest: Maria Pasioti Food allergy trials help us stay on the cutting edge by studying the latest treatment advances, but are we consistent in the terminology we use and even in the way we apply these findings to clinical practice? To find out, Dr. Jennifer Caudle welcomes Dr. Maria Pasioti, who discusses the design, endpoints, and real-world implications of food allergy trials.

Host: Jennifer Caudle, DO Guest: Maria Pasioti Food allergy trials help us stay on the cutting edge by studying the latest treatment advances, but are we consistent in the terminology we use and even in the way we apply these findings to clinical practice? To find out, Dr. Jennifer Caudle welcomes Dr. Maria Pasioti, who discusses the design, endpoints, and real-world implications of food allergy trials.

Host: Jennifer Caudle, DO Guest: Maria Pasioti Food allergy trials help us stay on the cutting edge by studying the latest treatment advances, but are we consistent in the terminology we use and even in the way we apply these findings to clinical practice? To find out, Dr. Jennifer Caudle welcomes Dr. Maria Pasioti, who discusses the design, endpoints, and real-world implications of food allergy trials.

Host: Jennifer Caudle, DO Guest: Maria Pasioti Food allergy trials help us stay on the cutting edge by studying the latest treatment advances, but are we consistent in the terminology we use and even in the way we apply these findings to clinical practice? To find out, Dr. Jennifer Caudle welcomes Dr. Maria Pasioti, who discusses the design, endpoints, and real-world implications of food allergy trials.

Guest: Maria Pasioti Here to give us a glimpse into the prevalence and impact of IgE-mediated food allergies in the EU is Dr. Maria Pasioti, an allergist at Laiko Hospital in Athens, Greece.

Guest: Maria Pasioti Here to give us a glimpse into the prevalence and impact of IgE-mediated food allergies in the EU is Dr. Maria Pasioti, an allergist at Laiko Hospital in Athens, Greece.

Guest: Maria Pasioti Here to give us a glimpse into the prevalence and impact of IgE-mediated food allergies in the EU is Dr. Maria Pasioti, an allergist at Laiko Hospital in Athens, Greece.

Guest: Maria Pasioti Here to give us a glimpse into the prevalence and impact of IgE-mediated food allergies in the EU is Dr. Maria Pasioti, an allergist at Laiko Hospital in Athens, Greece.

Host: Jennifer Caudle, DO Guest: Anne Ellis, MD Guest: George DuToit, MD Managing a food allergy can be difficult for both physicians and patients, which is why advocacy groups are working to advance the interests of this community and develop guidelines for healthcare professionals. To find out more, Dr. Jennifer Caudle is joined by Drs. Anne Ellis and George DuToit, who discuss their opinions and go into detail about how physicians can help patients living with a food allergy.

Host: Jennifer Caudle, DO Guest: Anne Ellis, MD Guest: George DuToit, MD Managing a food allergy can be difficult for both physicians and patients, which is why advocacy groups are working to advance the interests of this community and develop guidelines for healthcare professionals. To find out more, Dr. Jennifer Caudle is joined by Drs. Anne Ellis and George DuToit, who discuss their opinions and go into detail about how physicians can help patients living with a food allergy.

Host: Jennifer Caudle, DO Guest: Anne Ellis, MD Guest: George DuToit, MD Managing a food allergy can be difficult for both physicians and patients, which is why advocacy groups are working to advance the interests of this community and develop guidelines for healthcare professionals. To find out more, Dr. Jennifer Caudle is joined by Drs. Anne Ellis and George DuToit, who discuss their opinions and go into detail about how physicians can help patients living with a food allergy.

Host: Jennifer Caudle, DO Guest: Anne Ellis, MD Guest: George DuToit, MD Managing a food allergy can be difficult for both physicians and patients, which is why advocacy groups are working to advance the interests of this community and develop guidelines for healthcare professionals. To find out more, Dr. Jennifer Caudle is joined by Drs. Anne Ellis and George DuToit, who discuss their opinions and go into detail about how physicians can help patients living with a food allergy.

Host: Jennifer Caudle, DO Guest: Bruce Lanser, MD Guest: Drew Bird, MD Clinical trials are an important part of food allergy research, but there are some pretty big differences in the language that’s used to define primary endpoints and reported outcomes—not only here, but also abroad. Joining Dr. Jennifer Caudle to interpret the language that’s used in food allergy research and the implications of these different dialects are Drs. Drew Bird and Bruce Lanser.

Host: Jennifer Caudle, DO Guest: Bruce Lanser, MD Guest: Drew Bird, MD Clinical trials are an important part of food allergy research, but there are some pretty big differences in the language that’s used to define primary endpoints and reported outcomes—not only here, but also abroad. Joining Dr. Jennifer Caudle to interpret the language that’s used in food allergy research and the implications of these different dialects are Drs. Drew Bird and Bruce Lanser.

Host: Jennifer Caudle, DO Guest: Bruce Lanser, MD Guest: Drew Bird, MD Clinical trials are an important part of food allergy research, but there are some pretty big differences in the language that’s used to define primary endpoints and reported outcomes—not only here, but also abroad. Joining Dr. Jennifer Caudle to interpret the language that’s used in food allergy research and the implications of these different dialects are Drs. Drew Bird and Bruce Lanser.

Host: Jennifer Caudle, DO Guest: Bruce Lanser, MD Guest: Drew Bird, MD Clinical trials are an important part of food allergy research, but there are some pretty big differences in the language that’s used to define primary endpoints and reported outcomes—not only here, but also abroad. Joining Dr. Jennifer Caudle to interpret the language that’s used in food allergy research and the implications of these different dialects are Drs. Drew Bird and Bruce Lanser.

Host: Mario R. Nacinovich, Jr., MSc Guest: Jonathan Spergel, MD, PhD Get a bird’s-eye view of how oral immunotherapy (OIT) is developing in different countries with Dr. Mario Nacinovich and Dr. Jonathan Spergel, who also discusses the reasoning behind this strategy and when we should use this treatment option for our patients with food allergies.

Host: Mario R. Nacinovich, Jr., MSc Guest: Jonathan Spergel, MD, PhD Get a bird’s-eye view of how oral immunotherapy (OIT) is developing in different countries with Dr. Mario Nacinovich and Dr. Jonathan Spergel, who also discusses the reasoning behind this strategy and when we should use this treatment option for our patients with food allergies.

Host: Mario R. Nacinovich, Jr., MSc Guest: Jonathan Spergel, MD, PhD Get a bird’s-eye view of how oral immunotherapy (OIT) is developing in different countries with Dr. Mario Nacinovich and Dr. Jonathan Spergel, who also discusses the reasoning behind this strategy and when we should use this treatment option for our patients with food allergies.

Host: Mario R. Nacinovich, Jr., MSc Guest: Jonathan Spergel, MD, PhD Get a bird’s-eye view of how oral immunotherapy (OIT) is developing in different countries with Dr. Mario Nacinovich and Dr. Jonathan Spergel, who also discusses the reasoning behind this strategy and when we should use this treatment option for our patients with food allergies.

Host: Amy Mackey, MD Guest: Jay Lieberman, MD Guest: Alan Goldsobel, MD When it comes to managing patients with food allergy, what team members should contribute within your practice? To find out, Dr. Amy Mackey speaks with Drs. Jay Lieberman and Alan Goldsobel who discuss their food allergy care teams along with how they overcome common obstacles.

Host: Amy Mackey, MD Guest: Jay Lieberman, MD Guest: Alan Goldsobel, MD When it comes to managing patients with food allergy, what team members should contribute within your practice? To find out, Dr. Amy Mackey speaks with Drs. Jay Lieberman and Alan Goldsobel who discuss their food allergy care teams along with how they overcome common obstacles.

Host: Amy Mackey, MD Guest: Jay Lieberman, MD Guest: Alan Goldsobel, MD When it comes to managing patients with food allergy, what team members should contribute within your practice? To find out, Dr. Amy Mackey speaks with Drs. Jay Lieberman and Alan Goldsobel who discuss their food allergy care teams along with how they overcome common obstacles.

Host: Amy Mackey, MD Guest: Jay Lieberman, MD Guest: Alan Goldsobel, MD When it comes to managing patients with food allergy, what team members should contribute within your practice? To find out, Dr. Amy Mackey speaks with Drs. Jay Lieberman and Alan Goldsobel who discuss their food allergy care teams along with how they overcome common obstacles.

Guest: Jay Lieberman, MD As oral immunotherapy for food allergy continues to gain traction in clinical trials, Dr. Jay Lieberman shares four key takeaways regarding its side effects, whether it should be viewed as a cure, how it could potentially change a patient’s lifestyle, and ultimately, if it’s the answer for every patient with a food allergy.

Guest: Jay Lieberman, MD Food challenges can be done in a few different ways, and here to walk us through two types that are commonly used in research and clinical settings is Dr. Jay Lieberman, Associate Professor in the Department of Pediatrics at the University of Tennessee Health Science Center.

Guest: Jay Lieberman, MD As oral immunotherapy for food allergy continues to gain traction in clinical trials, Dr. Jay Lieberman shares four key takeaways regarding its side effects, whether it should be viewed as a cure, how it could potentially change a patient’s lifestyle, and ultimately, if it’s the answer for every patient with a food allergy.

Guest: Jay Lieberman, MD As oral immunotherapy for food allergy continues to gain traction in clinical trials, Dr. Jay Lieberman shares four key takeaways regarding its side effects, whether it should be viewed as a cure, how it could potentially change a patient’s lifestyle, and ultimately, if it’s the answer for every patient with a food allergy.

Guest: Jay Lieberman, MD Food challenges can be done in a few different ways, and here to walk us through two types that are commonly used in research and clinical settings is Dr. Jay Lieberman, Associate Professor in the Department of Pediatrics at the University of Tennessee Health Science Center.

Guest: Jay Lieberman, MD Food challenges can be done in a few different ways, and here to walk us through two types that are commonly used in research and clinical settings is Dr. Jay Lieberman, Associate Professor in the Department of Pediatrics at the University of Tennessee Health Science Center.

Guest: Brian P. Vickery, MD To help address some common concerns, a recent study from the PALISADE group of clinical investigators looked at the safety and efficacy of peanut oral immunotherapy. So what exactly did the study find? Here to review the trial’s promising results is Dr. Brian Vickery. In addition to being the lead author of the study, he’s also an Associate Professor of Pediatrics and Director of the Food Allergy Center of Children’s Healthcare of Atlanta at Emory University.

Guest: Brian P. Vickery, MD To help address some common concerns, a recent study from the PALISADE group of clinical investigators looked at the safety and efficacy of peanut oral immunotherapy. So what exactly did the study find? Here to review the trial’s promising results is Dr. Brian Vickery. In addition to being the lead author of the study, he’s also an Associate Professor of Pediatrics and Director of the Food Allergy Center of Children’s Healthcare of Atlanta at Emory University.

Host: Amy Mackey, MD Guest: Brian P. Vickery, MD In an effort to help physicians provide better care for those patients at risk of unpredictable—and potentially life-threatening—allergic reactions, the PALISADE group of clinical investigators explored oral immunotherapy as a potential treatment. Joining Dr. Amy Mackey to review these findings is the study’s lead author, Dr. Brian Vackey. He’s also an Associate Professor of Pediatrics and Director of the Food Allergy Center of Children’s Healthcare of Atlanta at Emory University.

Guest: Brian P. Vickery, MD To help address some common concerns, a recent study from the PALISADE group of clinical investigators looked at the safety and efficacy of peanut oral immunotherapy. So what exactly did the study find? Here to review the trial’s promising results is Dr. Brian Vickery. In addition to being the lead author of the study, he’s also an Associate Professor of Pediatrics and Director of the Food Allergy Center of Children’s Healthcare of Atlanta at Emory University.

Host: Amy Mackey, MD Guest: Brian P. Vickery, MD In an effort to help physicians provide better care for those patients at risk of unpredictable—and potentially life-threatening—allergic reactions, the PALISADE group of clinical investigators explored oral immunotherapy as a potential treatment. Joining Dr. Amy Mackey to review these findings is the study’s lead author, Dr. Brian Vackey. He’s also an Associate Professor of Pediatrics and Director of the Food Allergy Center of Children’s Healthcare of Atlanta at Emory University.

Host: Amy Mackey, MD Guest: Brian P. Vickery, MD In an effort to help physicians provide better care for those patients at risk of unpredictable—and potentially life-threatening—allergic reactions, the PALISADE group of clinical investigators explored oral immunotherapy as a potential treatment. Joining Dr. Amy Mackey to review these findings is the study’s lead author, Dr. Brian Vackey. He’s also an Associate Professor of Pediatrics and Director of the Food Allergy Center of Children’s Healthcare of Atlanta at Emory University.

Guest: Brian P. Vickery, MD To help address some common concerns, a recent study from the PALISADE group of clinical investigators looked at the safety and efficacy of peanut oral immunotherapy. So what exactly did the study find? Here to review the trial’s promising results is Dr. Brian Vickery. In addition to being the lead author of the study, he’s also an Associate Professor of Pediatrics and Director of the Food Allergy Center of Children’s Healthcare of Atlanta at Emory University.

Host: Amy Mackey, MD Guest: Brian P. Vickery, MD In an effort to help physicians provide better care for those patients at risk of unpredictable—and potentially life-threatening—allergic reactions, the PALISADE group of clinical investigators explored oral immunotherapy as a potential treatment. Joining Dr. Amy Mackey to review these findings is the study’s lead author, Dr. Brian Vackey. He’s also an Associate Professor of Pediatrics and Director of the Food Allergy Center of Children’s Healthcare of Atlanta at Emory University.

Host: Amy Mackey, MD Guest: Ruchi Gupta, MD, MPH Before we are able to improve how we address, research, and treat food allergies, we must first better understand the true prevalence and severity of this health threat. To help close this knowledge gap, Professor of Pediatrics at Northwestern University’s Feinberg School of Medicine Dr. Ruchi Gupta reveals key findings from The Public Health Impact of Parent-Reported Childhood Food Allergies in the United States study.

Host: Amy Mackey, MD Guest: Ruchi Gupta, MD, MPH Before we are able to improve how we address, research, and treat food allergies, we must first better understand the true prevalence and severity of this health threat. To help close this knowledge gap, Professor of Pediatrics at Northwestern University’s Feinberg School of Medicine Dr. Ruchi Gupta reveals key findings from The Public Health Impact of Parent-Reported Childhood Food Allergies in the United States study.

Host: Amy Mackey, MD Guest: Ruchi Gupta, MD, MPH Before we are able to improve how we address, research, and treat food allergies, we must first better understand the true prevalence and severity of this health threat. To help close this knowledge gap, Professor of Pediatrics at Northwestern University’s Feinberg School of Medicine Dr. Ruchi Gupta reveals key findings from The Public Health Impact of Parent-Reported Childhood Food Allergies in the United States study.

Host: Kathy King, RDN It's estimated that 4 - 8% of the U.S. population has at least one food allergy, and the incidence rate appears to be growing. How do we explain this harmful trend in public health, and what can clinicians and patients do to help mitigate the risk of developing food allergies? Host Kathy King is joined by Debra Indorato, nutrition advisor for Kids With Allergies, which is a division of the Asthma and Allergy Foundation of America. The two discuss the latest understandings and dietetic approaches to food allergies, sensitivities, and intolerances.

Host: Matt Birnholz, MD The simple act of going out to eat can be a tricky proposition for people dealing with gluten intolerance or sensitivity issues. A new portable device is aiming to help people with this problem by allowing them to test food's gluten content and help find foods that they are able to eat. Host Dr. Matt Birnholz talks with guest Carla Borsoi, Vice President of Marketing at 6Sensor Labs, about how this device will assist people living with gluten intolerance or sensitivity issues.